Proton Pump Inhibitors Accelerate Endothelial Senescence

Gautham Yepuri, Roman Sukhovershin, Timo Z. Nazari-Shafti, Michael Petrascheck, Yohannes T. Ghebre, John P. Cooke

Producción científica: Articlerevisión exhaustiva

123 Citas (Scopus)

Resumen

Rationale: Proton pump inhibitors (PPIs) are popular drugs for gastroesophageal reflux, which are now available for long-term use without medical supervision. Recent reports suggest that PPI use is associated with cardiovascular, renal, and neurological morbidity. Objective: To study the long-term effect of PPIs on endothelial dysfunction and senescence and investigate the mechanism involved in PPI-induced vascular dysfunction. Methods and Results: Chronic exposure to PPIs impaired endothelial function and accelerated human endothelial senescence by reducing telomere length. Conclusions: Our data may provide a unifying mechanism for the association of PPI use with increased risk of cardiovascular, renal, and neurological morbidity and mortality.

Idioma originalEnglish (US)
Páginas (desde-hasta)e36-e42
PublicaciónCirculation research
Volumen118
N.º12
DOI
EstadoPublished - jun 10 2016
Publicado de forma externa

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology

Huella

Profundice en los temas de investigación de 'Proton Pump Inhibitors Accelerate Endothelial Senescence'. En conjunto forman una huella única.

Citar esto